e l f Beauty Inc vs Ionis Pharmaceuticals Inc. Common Stock — how do they compare? e l f Beauty Inc trades at $107.01 (market cap $6.38B), while Ionis Pharmaceuticals Inc. Common Stock trades at $42.5 (market cap $7.04B). The key difference: e l f Beauty Inc and Ionis Pharmaceuticals Inc. Common Stock are close in size by market cap, and e l f Beauty Inc is trading nearer its 52-week high, Ionis Pharmaceuticals Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold e l f Beauty Inc for 26 Days and Ionis Pharmaceuticals Inc. Common Stock for 0 Days on average.
| ELF | IONS | |
|---|---|---|
Market Cap | $6.38B | $7.04B |
Volume | 856,198 | 2,977,440 |
Sector | Consumer Staples | Health |
52-Week High | $136.92 | $86.50 |
52-Week Low | $49.57 | $42.38 |
Typical Hold Time | 26 Days | 0 Days |
Enterprise Value | $6.97B | $6.60B |
Signals from Pluang's Aura AI — not financial advice
ELF Beauty trades at $108.16, down 1.62% today, with strong technical momentum showing bullish moving averages but overbought RSI readings. The company demonstrates robust revenue growth with Q2 2026 earnings beating expectations by 145%, though valuation metrics remain elevated with a P/E of 110.37. Recent expansion includes rhode brand launches in 19 European markets via Sephora and innovative marketing campaigns like the 'Mirror Mix' music album.
Outlook remains positive with analyst consensus leaning bullish (48% buy ratings) despite premium valuation. Key opportunities include international expansion and market share gains, while risks center on margin compression and competitive pressures in the beauty sector. The stock trades above consensus price target of $95.91, suggesting near-term consolidation potential.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →